Marketing-authorisation holder · United States
Cubist Pharms LLC
10 medicines in 2 countries, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
10 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CUBICIN250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Powder | Daptomycin | United States | Not marketed | 2003 |
| CUBICIN RF500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Powder | Daptomycin | United States | Not marketed | 2003 |
| DIFICID200mg · Tablet | Fidaxomicin | United States | Marketed | 2011 |
| DIFICID40mg/ml · For suspension | Fidaxomicin | United States | Marketed | 2020 |
| ENTEREG12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule | Alvimopan | United States | Not marketed | 2008 |
| SIVEXTRO200mg · Tablet | Tedizolid | United States | Marketed | 2014 |
| SIVEXTRO200mg/vial · Powder | Tedizolid | United States | Marketed | 2014 |
| ZERBAXA1gm base/vial; 0.5gm base/vial · Powder | Ceftolozane, Tazobactam | United States | Marketed | 2014 |
| CUBICIN500 mg / vial · Powder For Solution | Daptomycin | Canada | Cancelled | 2007 |
| CUBICIN RF500 mg / vial · Powder For Solution | Daptomycin | Canada | Cancelled | 2018 |